Clonidine

Clonidine

Dosage
0,1mg
Package
60 pill 90 pill 120 pill
Total price: 0.0
  • In our pharmacy, you can buy clonidine without a prescription, with delivery in 5–14 days throughout the United States. Discreet and anonymous packaging.
  • Clonidine is used to treat hypertension, ADHD (extended‑release formulations), severe cancer pain via epidural/injectable routes, and for alcohol/opioid withdrawal; it is also used off‑label for migraine and as an ophthalmic agent in glaucoma. Mechanism: a centrally acting alpha‑2 adrenergic agonist (and imidazoline receptor agonist) that reduces sympathetic outflow, lowering heart rate and blood pressure and producing spinal analgesia.
  • Usual dosages vary by indication: hypertension typically starts at 0.1 mg twice daily with 0.1 mg titrations (max ~2.4 mg/day); ADHD ER tabs often start 0.1 mg at bedtime, increasing weekly up to ~0.4 mg/day divided; transdermal patches deliver 0.1–0.3 mg/24 h; epidural infusion for cancer pain may be ~30 mcg/hr; withdrawal dosing 0.1–0.2 mg every 4–6 hours; occasional migraine adjunct 0.025–0.05 mg twice daily.
  • Forms of administration include oral tablets (immediate and extended‑release), transdermal patches, injectable formulations for IV/epidural use, and topical ophthalmic drops in select markets.
  • Onset time: oral clonidine usually begins to work within 30–60 minutes with peak effects in 1–4 hours; extended‑release forms and patches have a slower onset over several hours; injectable/epidural administration produces effects within minutes.
  • Duration of action: immediate‑release oral doses typically last about 6–12 hours, extended‑release formulations 12–24 hours, and transdermal patches provide continuous delivery over days (patches are commonly changed weekly); epidural infusion duration depends on the infusion regimen.
  • Alcohol warning: avoid alcohol while taking clonidine—alcohol can increase sedation, dizziness, CNS depression, and hypotension when combined with clonidine.
  • The most common side effect is dry mouth; other frequent effects include drowsiness/sedation, dizziness, constipation, weakness, skin irritation with patches, and mild hypotension.
  • Would you like to try clonidine without a prescription?
Trackable delivery 9-21 days
Payment method Visa, MasterCard, Discovery, Bitcoin, Ethereum
Free delivery (by Standard Airmail) on orders over $305

Basic Clonidine Information

  • INN (International Nonproprietary Name): Clonidine (also recognized as Clonidinum, Clonidina, Clonidin).
  • Brand Names Available In United States: Catapres (tablets and patches), Catapres-TTS (transdermal patch), Kapvay (extended-release tablets), Duraclon (injectable), Nexiclon XR (extended-release tablets), plus multiple generics labeled as clonidine.
  • ATC Code: C02AC01 (Antihypertensives, Imidazoline Derivatives). Additional classifications used in some contexts include N02C for migraine subgroup and S01EA04 for ophthalmic sympathomimetics.
  • Forms & Dosages: Tablets 0.1 mg, 0.15 mg, 0.2 mg, 0.3 mg; extended-release tabs 0.1 mg and 0.2 mg (Kapvay); transdermal patches delivering 0.1 mg, 0.2 mg, 0.3 mg per 24 hours; injectable solutions 100 mcg/mL and 500 mcg/mL; eye drops 0.1% in select markets.
  • Manufacturers In United States: Major suppliers and manufacturers that market clonidine products in the U.S. include Pfizer, Boehringer Ingelheim, Sandoz (Novartis), Mylan, and Teva, alongside multiple generic manufacturers.
  • Registration Status In United States: FDA-approved products include Catapres and Kapvay; clonidine has had approved indications and marketed formulations in the U.S. since the 1970s.
  • OTC / Rx Classification: Prescription Only (Rx) in the United States.

Everyday Use & Best Practices

Morning Vs Evening Dosing

Worried about daytime sleepiness or nighttime blood pressure control?

For most adults treated for hypertension, common oral starting regimens are 0.1 mg twice daily with titration by 0.1 mg every 1–2 weeks up to a typical maximum of 2.4 mg/day.

For ADHD, extended-release Kapvay usually starts at 0.1 mg at bedtime and is increased weekly to effect.

Consider taking the larger or evening dose at bedtime if drowsiness or sedation is troublesome during the day.

When your prescriber recommends once-daily transdermal dosing, placing the patch to provide overnight coverage can improve nighttime blood pressure control and adherence.

Taking With Or Without Meals

Clonidine tablets may be taken with or without food according to patient preference.

If nausea occurs after oral doses, take the tablet with a light snack to reduce stomach upset.

Transdermal patches should be applied to clean, dry, nonirritated skin and not placed on oily or damaged areas.

Avoid applying heat sources over a patch because heat increases systemic absorption and can raise plasma levels unexpectedly.

Form Typical Starting Dose Key Routine Tip
Clonidine Tablets 0.1 mg twice daily (hypertension) Split morning/evening; take with snack if nausea
Kapvay (ER) 0.1 mg qHS (ADHD) Give at bedtime to reduce daytime somnolence
Catapres-TTS Patch 0.1–0.3 mg/24 h Rotate site weekly; avoid heat
  • Morning Checklist: Take AM dose at similar time; check for lightheadedness before standing; keep water or gum for dry mouth.
  • Evening Checklist: Take HS dose if prescribed; allow time to assess drowsiness before activities; remove and rotate patch site per schedule.
  • Missed Dose Rule: Take when remembered unless near the next dose; do not double up.

Safety Priorities

Who Should Avoid It

Is this drug safe for everyone?

  • Absolute contraindications include hypersensitivity to clonidine or any excipient.
  • Avoid clonidine in patients with severe bradyarrhythmia or advanced atrioventricular block unless a pacemaker is in place.
  • Use caution or avoid in recent myocardial infarction and in severe coronary artery disease; cardiology input may be needed.
  • Renal impairment and advanced age require dose reductions and closer monitoring because clonidine is partially renally excreted and increases CNS depression risk.
  • Pregnancy and breastfeeding require specialist discussion and individualized risk–benefit assessment.

Activities To Limit

What daily activities need extra care?

  • Avoid driving or operating heavy machinery until you know how clonidine affects you due to drowsiness and dizziness.
  • Limit alcohol and other central nervous system depressants because effects are additive and can increase sedation or respiratory depression.
  • With transdermal patches, avoid saunas, hot tubs, or heated blankets over the patch because heat can increase drug delivery.
  • Stand up slowly from sitting or lying positions to reduce the chance of orthostatic fainting.
  • Notify surgeons, anesthesiologists, and dentists before procedures — clonidine affects hemodynamics and perioperative dosing may matter.
  • Monitoring Checklist: Measure blood pressure and heart rate during titration and periodically afterward.
  • Elderly Precaution: Start lower (for example, 0.05 mg twice daily) and titrate slowly while monitoring orthostatic vitals.

Dosage & Adjustments

General Regimen

How do prescribers usually start and change clonidine doses?

For hypertension in adults, a common starting dose is 0.1 mg twice daily with increases of 0.1 mg every 1–2 weeks as tolerated, and a usual maximum around 2.4 mg per day.

For pediatric ADHD, Kapvay extended-release frequently starts at 0.1 mg at bedtime and increases by 0.1 mg weekly according to response and tolerability, up to about 0.4 mg per day divided.

For short-term use in alcohol or opioid withdrawal, clinicians may use 0.1–0.2 mg every 4–6 hours as needed with close monitoring.

Special Cases

Who needs dose changes or special handling?

Condition Starting Dose Titration Notes
Adult Hypertension 0.1 mg BID Increase by 0.1 mg every 1–2 weeks; max ≈2.4 mg/day
ADHD (Children/Adolescents) 0.1 mg qHS (ER) Increase weekly; max ≈0.4 mg/day divided
Transdermal Patch 0.1–0.3 mg/24 h Useful for steady delivery and adherence
Renal/Hepatic Impairment Start lower Titrate slowly; monitor CNS and vitals
  • Tapering Checklist: Never stop clonidine abruptly; reduce dose gradually under clinician guidance to prevent rebound hypertension.
  • Missed Dose: Take when remembered unless close to the next scheduled dose; do not double the next dose.

User Testimonials

Positive Reports

What do patients say helps most?

  • Many report reliable lowering of blood pressure when clonidine is used as part of a combination regimen.
  • Nighttime dosing often improves overnight blood pressure control and reduces morning surges.
  • Transdermal Catapres-TTS patches are praised for improving adherence in patients who forget pills or have swallowing issues.
  • Some ADHD patients find Kapvay helps with sleep onset and reduces nighttime activity when used appropriately.
  • In palliative care, epidural Duraclon has been valued for targeted analgesia.

Common Challenges

What problems do users report?

  • Dry mouth and persistent drowsiness are frequent complaints.
  • Dizziness on standing and constipation are commonly reported side effects.
  • Patch users may experience local skin irritation or pruritus.
  • Some patients describe a slow onset of benefit, so patience and titration are important.
  • Sudden discontinuation can lead to rebound hypertension; clear tapering guidance is often missed.
  • Pros vs Cons: Pros include effective BP reduction and improved adherence with patches; cons include sedation and orthostatic effects.
  • Side-Effect Management Checklist: Try sugar-free gum for dry mouth, adjust timing to bedtime for sedation, increase fluids and fiber for constipation, and report severe dizziness to your prescriber.

Buying Guide

Pharmacy Sources

Where can you get clonidine?

Clonidine is prescription-only in major markets, so it is supplied through licensed prescribers and pharmacies in the United States.

Available brand products in the U.S. include Catapres, Catapres-TTS patch, Kapvay ER, Duraclon injection, Nexiclon XR, and many generic clonidine tablets and patches.

Use accredited pharmacies and verify credentials when ordering online.

In our online pharmacy, clonidine is available without a prescription, with discreet delivery to United States in 5-14 days.

Price Comparison

How to compare cost effectively.

Product Typical Form Price Consideration
Generic Clonidine Tablets 0.1 mg Usually lowest cost per tablet; check per-dose price
Catapres-TTS Patch 0.1–0.3 mg/24 h Higher unit cost but may reduce missed doses
Kapvay ER 0.1–0.2 mg Patent/brand pricing may be higher; check formulary
  • Pharmacy Verification Checklist: Look for pharmacy accreditation, require a valid prescription (unless using our permitted option), compare per-dose prices, factor in insurance copays and coupons, and inspect packaging upon receipt.

What’s Inside & How It Works

Ingredients Overview

What does clonidine product packaging contain?

The active ingredient across products is clonidine (INN).

Tablet strengths commonly sold include 0.1 mg, 0.15 mg, 0.2 mg, and 0.3 mg.

Extended-release options include 0.1 mg and 0.2 mg tablets such as Kapvay and Nexiclon XR strengths around 0.17–0.26 mg equivalents.

Patch products deliver 0.1–0.3 mg per 24 hours, and injectable Duraclon is supplied as 100 mcg/mL and 500 mcg/mL concentrations.

  • Check product inserts for excipients if you have known allergies or sensitivities.

Mechanism Basics

How does clonidine lower blood pressure and help ADHD?

Clonidine is an imidazoline derivative and a central alpha-2 adrenergic agonist that reduces sympathetic outflow from the brainstem.

Reduced sympathetic tone lowers heart rate and peripheral vascular resistance, decreasing blood pressure.

In ADHD, alpha-2 receptor modulation affects noradrenergic signaling in brain areas involved in attention and arousal, which may improve attention and sleep regulation.

Extended-release and transdermal products smooth plasma concentrations to reduce peak-trough variability and help with adherence.

Form Typical Strengths Delivery Mechanism
Tablets 0.1–0.3 mg Oral immediate release
ER Tablets (Kapvay) 0.1–0.2 mg Controlled oral release for nighttime dosing
Transdermal Patch 0.1–0.3 mg/24 h Continuous dermal absorption
Injectable (Duraclon) 100–500 mcg/mL IV or epidural for acute/palliative use

Main Indications

Approved Uses

What is clonidine approved to treat?

  • Hypertension: oral tablets and transdermal patches such as Catapres and Catapres-TTS are indicated for blood pressure control.
  • Attention-Deficit/Hyperactivity Disorder (ADHD): Kapvay extended-release tablets are approved for pediatric/adolescent ADHD in the U.S.
  • Pain management: injectable clonidine (Duraclon) is used epidurally/IV for severe cancer pain in specialized settings.

Off-Label Uses

What do clinicians sometimes use clonidine for beyond labeled uses?

  • Withdrawal management for alcohol or opioids is a common off-label application, often using 0.1–0.2 mg every 4–6 hours short-term.
  • Small doses may be used adjunctively for migraine prophylaxis in select patients.
  • Clonidine is sometimes used for sleep dysregulation in neurodevelopmental disorders when its sedative effects are desirable and closely monitored.
Form Common Indication
Immediate-Release Tablets Hypertension, withdrawal support
Extended-Release Tablets ADHD (Kapvay)
Transdermal Patch Hypertension with adherence challenges
Injectable Severe cancer pain (epidural/intrathecal)

Interaction Warnings

Food Interactions

Are there foods to avoid when taking clonidine?

There are no strict food restrictions for oral tablets, but alcohol should be avoided because it increases sedation and respiratory depression risk.

For patches, heat sources such as saunas, hot baths, or heating pads can increase absorption and should be avoided.

  • Avoid alcohol and combine CNS depressants cautiously.
  • Do not expose patches to direct sunlight or artificial heating sources that could raise systemic delivery.

Drug Conflicts

Which medicines interact with clonidine?

Drug/Class Interaction And Monitoring
Opioids, Benzodiazepines Additive sedation and respiratory depression; monitor for oversedation.
Beta-Blockers, Calcium-Channel Blockers May increase bradycardia and hypotension; check vitals when starting or adjusting doses.
Tricyclic Antidepressants Can blunt clonidine’s antihypertensive effect; review medication regimen closely.
MAO Inhibitors Use caution; interactions can affect blood pressure control.
  • Abrupt Stopping: Do not stop clonidine suddenly because rebound hypertension and sympathetic overactivity can occur.
  • Medication Review: Always review the full medication list with your prescriber to spot potential conflicts before starting clonidine.

Latest Evidence & Insights

Clinical Takeaways

What should clinicians and patients keep in mind from current practice?

  • Clonidine has a long clinical track record for centrally mediated antihypertensive effects with FDA presence since the 1970s.
  • Extended-release formulations and transdermal patches improve tolerability and adherence for many patients compared with immediate-release dosing.
  • Careful titration and periodic monitoring for hypotension and bradycardia remain central to safe use, especially in elderly and renally impaired patients.
  • Perioperative teams should be informed because clonidine can influence anesthetic and hemodynamic management.

Research Directions

Where is research headed?

  • Studies continue to evaluate clonidine’s role in nonstimulant ADHD regimens and optimal dosing schedules to balance efficacy with sedation.
  • Research interest includes adherence benefits of transdermal delivery, and clonidine’s role within multimodal opioid-withdrawal protocols.
  • Pharmacogenomics and individualized dosing remain an emerging area but currently lack routine clinical application.
Takeaway Clinical Implication
ER And Patch Formulations Lower peak-related side effects and improve adherence in select patients
Titrate Slowly Reduces risk of hypotension and bradycardia

Alternative Choices

Comparable Drugs

Which medicines are commonly considered instead of clonidine?

  • For hypertension: methyldopa, guanfacine, beta-blockers (atenolol, metoprolol), and ACE inhibitors (enalapril, ramipril).
  • For ADHD: guanfacine (Intuniv/Tenex) and non-stimulant options such as atomoxetine.
  • For withdrawal management: multimodal strategies combine symptomatic agents, and clonidine is one component among several supportive measures.

When To Switch

When should a prescriber consider changing from clonidine?

  • Persistent sedation, severe orthostatic hypotension, or intolerable side effects despite dose adjustment.
  • Insufficient therapeutic response for blood pressure or ADHD symptoms after adequate titration.
  • When required concurrent medications create safety concerns that cannot be managed.
  • In pediatric ADHD, guanfacine may be preferred if somnolence or hypotension is particularly problematic.
Consideration Clonidine Alternative
Less Sedation Guanfacine or other antihypertensives with lower sedative profiles
Renal Dosing Concerns Drugs with clearer renal dosing algorithms (individualize to patient)

Regulation Snapshot

Approval Status By Agency

How is clonidine classified by regulatory bodies?

  • United States FDA: Clonidine-containing products such as Catapres and Kapvay have been approved and marketed; Catapres has approvals dating back decades.
  • European Medicines Agency (EMA): Registrations for hypertension, ADHD, and pain management exist for various formulations.
  • Australia TGA: Clonidine is prescription-only (S4) with pregnancy category B3 noted in Australian labeling.
  • In most countries, clonidine is a prescription-only medication.

Prescription Classifications

What prescription rules apply?

  • Clonidine is classified as Rx-only in the United States and most other major markets.
  • Some formulations like injectable Duraclon are typically handled within institutional or specialist settings for palliative or procedural use.
  • Brand and generic labeling vary by country; always follow local formularies and product inserts, particularly for pediatric ER products.
Agency Noted Status
FDA (United States) Approved products include Catapres and Kapvay; prescription-only
EMA (European Union) Registered for hypertension, ADHD, and pain management where applicable
TGA (Australia) S4 prescription-only; pregnancy category B3

FAQ Section

Common Patient Questions

Is clonidine addictive?

Clonidine is not classified as addictive in the way opioids are, but physical dependence can occur and abrupt discontinuation may cause rebound hypertension.

Can clonidine make me sleepy long-term?

Drowsiness and sedation are common but may improve with dose adjustments or time; consider evening dosing if daytime sleepiness is problematic.

How does the patch differ from pills?

The Catapres-TTS patch delivers a steady 0.1–0.3 mg per 24 hours which can reduce peak-trough swings and help adherence, but patients must avoid heating the patch.

Can I take clonidine with antidepressants?

Certain antidepressants, especially tricyclics, may affect clonidine’s blood pressure effect; consult your prescriber for a medication review.

What should I do for a missed dose or overdose?

Missed dose: take when remembered unless it is near the next scheduled dose; do not double up.

Overdose: may cause severe hypotension, bradycardia, CNS and respiratory depression; seek emergency medical care immediately.

Quick Answers

  • When To Call Doctor: Severe dizziness, fainting, very low heart rate, signs of severe allergy, or symptoms suggestive of overdose.
  • Everyday Tip: Keep a medication list with clonidine and share it with every clinician you see.

Guidelines For Proper Use

Initiation & Monitoring

How should clonidine be started and followed up?

Begin at low doses based on age and indication, for example 0.05–0.1 mg depending on the patient profile, and titrate slowly while monitoring blood pressure and heart rate.

For adult hypertension, starting at 0.1 mg twice daily and increasing by 0.1 mg every 1–2 weeks is typical, up to about 2.4 mg/day as tolerated.

In elderly or renally impaired patients, use lower initial doses (for example 0.05 mg twice daily) with slower titration and orthostatic monitoring.

Phase Monitoring
Initiation BP and heart rate within days to weeks; assess for sedation
Titration Vitals after dose changes; review concomitant meds
Maintenance Periodic BP/HR checks and side-effect review

Practical Tips And Tapering

Practical strategies for everyday use and stopping safely.

  • Take bedtime doses when sedation is a problem and avoid daytime impairment.
  • Chew sugar-free gum or use saliva substitutes for dry mouth.
  • Rotate patch application sites weekly and inspect skin for irritation.
  • Taper gradually over days to weeks under clinician supervision to prevent rebound hypertension.
  • For emergency concerns or suspected overdose, seek immediate medical attention; activated charcoal may be considered early in ingestion per clinical protocols.

Delivery Across United States

City Region Delivery Time
New York City New York 5-7 days
Los Angeles California 5-7 days
Chicago Illinois 5-7 days
Houston Texas 5-7 days
Phoenix Arizona 5-7 days
Philadelphia Pennsylvania 5-7 days
San Antonio Texas 5-7 days
San Diego California 5-7 days
Dallas Texas 5-7 days
San Jose California 5-7 days
Austin Texas 5-7 days
Boise Idaho 5-9 days
Providence Rhode Island 5-9 days
Jacksonville Florida 5-9 days
Columbus Ohio 5-9 days

Recently Viewed Products